Vital Status

Date of last contact or death

Has the patient had a documented clinical assessment for this cancer since submission of the previous follow-up form? (If Yes, )

Date of Last Clinical Assessment

Has the patient developed a first relapse or progression that has not been previously reported? (If Yes)

Date of Relapse or Progression

Site(s) of Relapse or Progression

Has a new primary cancer or myelodysplastic syndrome (MDS) been diagnosed that has not been previously reported? (If Yes,)

New Primary Site

Has the patient received any non-protocol cancer therapy (prior to progression/relapse) not previously reported? (If Yes)

Date of First Non-Protocol Therapy

Agents

Has the patient experienced (prior to treatment for progression or relapse or a second primary, and prior to non-protocol treatment) any severe (grade 3) long term toxicity that has not been previously reported? (If Yes,)

Toxicities and Grades

Notes

SWOG Patient ID

SWOG Study No.

Registration Step

Patient Initials (L, F, M)

Institution/Affiliate

Physician

Group Name

Study No.

Pt. ID